Recent Headlines
Within Biotechnology
A Full Pipeline of Follow-on TNF-Antagonists
The US$ 7.6 bln market of TNF-antagonists attracts numerous follow-on compounds including improved TNF-antagonists and molecules originating from new technologies. - August 02, 2006 - La Merie Business Intelligence
Five Top Colorado Bioscience Company CEOs Present at This Year’s BioWest Investor Forum
CEOs from five of Colorado’s top bioscience companies will present at the BioWest 2006 Investor Forum on August 24th – registration is still open for the two-day BioWest event, which is the Rocky Mountain Region’s premier bioscience conference and expo. CEOs featured in the Investor Forum include Paul Berns, Allos Therapeutics; John Serino, Encision; Bill Freytag, Myogen; Patrick Mahaffy, Pharmion; and Ken Collins, Replidyne. - July 28, 2006 - Colorado BioScience Association
CytoCore, Inc. Announces New Cancer Screening and Treatment System on the Horizon
CytoCore, Inc., a biomolecular diagnostics screening company committed to bringing new cancer solutions to the market, has announced the development of a new screening and treatment system. CytoCore has developed the InPath™ System, a cervical/uterine cancer screening and treatment system... - July 24, 2006 - CytoCore
Baxa Corporation Named One of 25 Best Companies to Work for in Colorado
Englewood-based Baxa Corporation has been selected one of the 25 best companies to work for in Colorado following employee surveys by the Society for Human Resource Management (SHRM). The recognition is a result of the responses received from an electronic survey sent to most of the company’s Colorado-based associates in April. The Best Companies initiative honors Colorado companies that show dedication to their employees’ growth and quality of life. - July 21, 2006 - Baxa Corporation
Baxa Selected One of 50 ‘Companies to Watch’ in the Medical Device Industry
Medical Device and Diagnostic Industry (MD&DI) magazine has selected Colorado-based Baxa Corporation as a notable company in its review of medical device manufacturers and their contributions The magazine chose companies with formidable track records or the potential for success, and technology breakthroughs or transformations of standards of care that its editors feel are worth monitoring. This is the first year that Baxa has won this designation. - July 14, 2006 - Baxa Corporation
Seven Finalists Selected for The BioWest 2006 Venture Showcase Competition, Presenting World-Changing Technologies
Novel cancer drugs; innovative treatments for blood cancers and clotting; new ways to attack inflammatory and infectious diseases; ground-breaking compounds to treat osteoporosis and metastatic bone disease; pioneering devices for orthopedic surgery; commercializing biofuels from algae; and revolutionary wearable rehabilitation systems comprise the seven finalists in this year’s BioWest Veture Showcase competition. - July 11, 2006 - Colorado BioScience Association
Electronic Sleep Aid Provides Unparalleled Athletic Performance Enhancement
EarthPulse™ enhances athletic performance in world class and amateur competitors safely and more effectively than anabolic steroids or blood doping, while significantly improving their sleep. - July 09, 2006 - EarthPulse Tech, LLC
CytoCore Retains MMI Associates, Inc.
Raleigh PR firm to provide public relations and product marketing services to Uterine and Cervical Cancer screening firm. - July 08, 2006 - CytoCore
New ValiMed™ Medication Validation System Demonstrates USP 797 Compliance at ASHP Summer Meeting
Baxa Corporation demonstrates the next-generation ValiMed System for medication safety at booth no. 729 at the American Society of Health-System Pharmacists Summer Meeting June 25 – 28 in Orlando, Fla. The next-generation ValiMed Technology offers the same benefits as the original system, with additional reporting features and a smaller sample requirement. - June 26, 2006 - Baxa Corporation
Baxa Ltd Launches New CyTwo-Fer™ Needle for Safe Drug Reconstitution and Transfer
Baxa introduces a new 4 mm version of its CyTwo-Fer Needle. The unique dual-purpose device permits vented and non-vented use for vial reconstitution and withdrawal from drug vials and bags. - June 26, 2006 - Baxa Corporation
Baxa to Launch STAR Center for Professional Pharmacy and Cleanroom Training at ASHP Annual Meeting
Baxa Corporation will announce the development of a professional Skills Training, Academics and Resources (STAR) Center for pharmacy and cleanroom skills training at the Annual Meeting of the American Society of Health-System Pharmacists in Orlando, Florida. The STAR Center, a state-of-the-art facility designed for cleanroom and pharmacy practice demonstration, is located at the company’s world headquarters south of Denver, Colorado. - June 23, 2006 - Baxa Corporation
Tuberculosis and Air Travel - Free Webinar on July 24th
Healthcare professional, Stacey Lloyd, is offering a free webinar to discuss the risks of contracting tuberculosis during air travel at www.StaceyLloyd.com. This webinar will be available to air travelers and healthcare personnel during the busy travel season. - June 20, 2006 - Pharmaceutical Resources Group
Biogenerics and New Technologies Compete with 1st Generation Major Products
The US$ 32 bln market of six major protein products is enfacing competition by less costly biogenerics and by improved products via drug delivery or protein engineering technologies and even oral, small molecule solutions. - June 20, 2006 - La Merie Business Intelligence
Baxa Launches New 35 mL Exacta-Med® Oral Dispenser
New size of Exacta-Med® Oral Dispenser completes the product range – from 0.5 to 60 mL – of safe oral medication dispensers for market leader Baxa Corporation. Exacta-Med Oral Dispensers play a vital role in preventing wrong-route administration of non-IV fluid drugs. Their unique dispenser tip cannot connect to a luer needle hub or a needleless IV system. - June 13, 2006 - Baxa Corporation
Baxter Black and Ira Flatow Lead the Lineup of Presenters for Biowest 2006, Now Open for Registration
Registration is now open for the Rocky Mountain Region’s Premier Bioscience Conference and Expo, BioWest 2006. More than 750 participants are expected at this year’s event, August 23-24, at the Colorado Convention Center in Denver. America’s “Cowboy Poet” Baxter Black and NPR Science Friday® host Ira Flatow are the headliners for Biowest 2006, along with the presentation, “Where Innovation Happens” from Federal Reserve Executive Michael Orlando. - June 06, 2006 - Colorado BioScience Association
Cornerstone BioPharma, Inc. and Athlon Pharmaceuticals Sign Co-Promotion Agreement
Cornerstone BioPharma™, the Triangle-based specialty pharmaceutical company currently focused on the development and commercialization of niche prescription medications in the respiratory arena, today announced the company has signed a co-promotion agreement with Athlon Pharmaceuticals... - June 06, 2006 - Cornerstone BioPharma
AnaSpec Introduces New Line of Reagents and Kits for Study of Protein Phosphorylation
AnaSpec, a leading provider of integrated proteomics solutions, has introduced an extensive new line of reagents and kits for the study of protein phosphorylation. Cellular phosphorylation is a reversible, covalent modification of a protein or lipid that serves to modify the activity of the... - June 06, 2006 - AnaSpec, EGT Group
Baxa Corporation Wins Two AMA Awards
At the Colorado American Marketing Association PEAK Awards ceremony, Baxa Corporation won the Gold Award for Direct Mail Campaign and the Annual Marketer of the Year Award. The direct mail award recognized the success of the company’s Real Pharmacy campaign, developed to generate customer testimonials for Baxa products. Marian Robinson, VP of Marketing for Baxa Corporation was recognized as Annual Marketer of the Year (AMY) for exemplifying outstanding marketing leadership and accomplishment. - June 05, 2006 - Baxa Corporation
Imminent Launches of New EPO Products and Consolidation of the Biogenerics Field
The Business Intelligence firm La Merie S.L. reported today changes in the field of erythropoiesis stimulating agents (ESA) observed in a follow-up analysis. The first launch of a new ESA in Europe is expected to be Shire’s epoetin omega in the first half of 2007 to be followed by... - June 03, 2006 - La Merie Business Intelligence
Localized Delivery of PDE-4 Inhibitors to Open the Therapeutic Window
The Localized delivery of phosphodiesterase-4 (PDE-4) inhibitors appears to be short term solution to overcome the dose-limiting side effects of severe nausea and emesis occurring after oral administration. In the long-term, subtype-selective PDE-4 inhibitors and combination regimens may help to improve the therapeutic index. - May 31, 2006 - La Merie Business Intelligence
WellAware™ Error-Free Light Guided Manual Pipetting System is Now Application Based
BioTX has finished the development of an application based, light guided manual pipetting system called WellAware which is ideal for forensic, paternity, life science, pharmaceutical, preclinical and chemistry labs. WellAware provides lab managers with an inexpensive alternative or supplement to full automation. WellAware is configured right out of the box for PCR, DNA sequencing, genotyping, microplate transpositions, dilutions, normalizations, microplate reformatting and cherry-picking. - May 25, 2006 - BioTX Automation, Inc.
The Next Generation of Interferons Needs Improvement in Efficacy and Safety
The interferon alpha market is smaller than the interferon beta market, but is characterized by far more products and R&D projects. Conversion of the interferon alpha market to pegylated products explains why new R&D is focused on interferon alpha variants or other subtypes with improved pharmacodynamic and safety properties. - May 19, 2006 - La Merie Business Intelligence
Now available on CD: Baxa Corporation Exhibitor’s Theatre Offering, 'What’s Next with USP 797?' from ASHP Midyear Clinical Meeting
Colorado-based pharmacy products manufacturer, Baxa Corporation now has a CD available of the presentation, 'What’s Next with USP 797?' from the annual American Society of Health-System Pharmacists Midyear Clinical Meeting in Las Vegas. Eric Kastango, MBA, RPh, discussed the proposed changes to the USP 797 guidelines for sterile compounding and the impact on the hospital pharmacy practice. - May 10, 2006 - Baxa Corporation
RNA Interference (RNAi) is Coming of Age as a Therapeutic Modality
The Business Intelligence firm La Merie S.L. reported today that the RNAi therapeutic pipeline is rapidly filling and advancing towards clinical development. Four RNAi therapeutic projects are in early clinical development. At least 32 RNAi projects are in preclinical development in a variety of... - May 10, 2006 - La Merie Business Intelligence
BioWest 2006 Organizers Seek the Best and Brightest of the Rocky Mountain Region’s Bioscience Start-Ups for the Venture Showcase Competition
BioWest, The Rocky Mountain Region’s Premier Bioscience Conference and Expo, is again looking for the best bioscience start-ups in the region as candidates for the $10,000 Faegre & Benson Venture Showcase Award. Seven companies will be chosen to present at the Showcase in August, which will be judged by a panel of national venture capitalists. Deadline for entry is June 8, 2006. - May 09, 2006 - Colorado BioScience Association
Pharmaceutical Resources Group Welcomes Mary Lou Freathy, JD, as its Newest Member
Freathy Brings Experience in Pharmaceutical Compliance and Quality Assurance to the Network. - May 04, 2006 - Pharmaceutical Resources Group
Baxa Corporation Registered to New ISO Standard Under BSI
Baxa Corporation has met the requirements for management systems conformity under the British Standards Institution for ISO-13485:2003. The company recently named BSI as its new registrar and completed its first official assessment with them. Previously, Baxa Corporation’s US and UK operations used different auditors for ISO and CE compliance. Under BSI, the company now has a single world-class auditor for both facilities. - May 03, 2006 - Baxa Corporation
EarthPulse® Very Weak Pulsed Electromagnetic Field (PEMF) Raises Saturated Blood Oxygen 3% During 12 Hours of Sleep
One night of EarthPulse® very weak pulsed electromagnetic field (PEMF) raises saturated blood oxygen 3%, inhalation volume 6% and breath-hold duration 7% in asthmatic American record holder. - April 28, 2006 - EarthPulse Tech, LLC
Baxa Corporation Wins BMA Colorado 2006 Gold Key Award
Baxa Corporation, Denver-based manufacturer of medical devices for healthcare systems, has won a 2006 Business Marketing Association Gold Key Award. The winning entry was the Baxa “One Less Thing” campaign, which promoted the safety and ease-of-use of the Exacta-Med® Oral Dispensers. The Baxa oral dispensers were the company’s first product, and still contribute greater than 30% of its revenues today. - April 27, 2006 - Baxa Corporation
2006-2007 Colorado Bioscience Magazine Unveiled At Colorado BioScience Association 2006 Annual Membership Meeting
Colorado BioScience Association released new 76-page issue of Bioscience Colorado Magazine at the 2006 Annual Membership Meeting. In addition, seven new appointments were made to the Board of Directors, along with eight reappointments; 2006 Corporate Sponsors were introduced; and Brandon Shaffer, Colorado State Senator District 17, was presented the national Biotechnology Industry Organization Legislator of the Year Award. - April 18, 2006 - Colorado BioScience Association
Seven New Board Members Named To The Colorado BioScience Association Board Of Directors At The 2006 Annual Membership Meeting
Seven new appointments were made to the Board of Directors of Colorado BioScience Association at its 2006 Annual Membership Meeting, along with eight reappointments. In addition, the 2006 Corporate Sponsors were released; Brandon Shaffer, Colorado State Senator District 17, was presented the national Biotechnology Industry Organization Legislator of the Year Award; and the 2006-2007 Bioscience Colorado Magazine was unveiled to members at the event. - April 18, 2006 - Colorado BioScience Association
State Senator Brandon Shaffer Receives National BIO Legislator of the Year Award at Colorado BioScience Association 2006 Annual Membership Meeting
Brandon Shaffer, Colorado State Senator District 17, was presented the national Biotechnology Industry Organization Legislator of the Year Award at the Colorado BioScience Association 2006 Annual Membership Meeting. The award was presented by Amgen Colorado’s Eric Bergenson. Senator Shaffer was singled out nationally for his ongoing and extensive support of the bioscience industry in the state. - April 18, 2006 - Colorado BioScience Association
Baxa Corporation Wins National Design Awards from Graphic Design USA Magazine
Two campaigns designed and executed by the Baxa in-house design team have been selected for 2006 American Inhouse Design Awards for creative work on a recent direct mail campaign (‘right equipment’) and a national customer promotion (‘real pharmacy’). Graphic Design USA – a national magazine for design professionals – has sponsored design competitions for four decades. The 2006 winners were chosen from nearly 3,500 submissions, less than 20% of which received awards. - April 13, 2006 - Baxa Corporation
Pulsed Electromagnetic System Speeds Germination Time and Nearly Doubles Size and Weight of Sprouted Beans
EarthPulse Technologies, LLC develops PEMF agriculture application capable of substantially cutting germination time and increasing growth rate of sprouted seeds and beans, proving that directed magnetic field forces can increase yield by weight over 90%. - April 11, 2006 - EarthPulse Tech, LLC
New Life Scientific Enters New Phase
New Life Scientific, Inc (NWLS), today announced that at the special meeting of the Board of Directors a decision was made to re-evaluate its current progress and review its future options being considered include reviewing opportunities to acquire, license, and/or joint venture various medical,... - April 11, 2006 - New Life Scientific, Inc.
Pharmaceutical Resources Group is Accepting New Members for its Free Online Network
PRG is Currently Accepting Pharmaceutical, Biotechnology, and Medical Device Professionals. - April 07, 2006 - Pharmaceutical Resources Group
Baxa Corporation Announces Its UK Subsidiary, Baxa Ltd, to Expand into New Facilities, More than Doubling in Size from the Present Location
International healthcare-product manufacturer, Baxa Ltd, UK subsidiary of Denver-based Baxa Corporation, announces the relocation of its sales and marketing operations to Bracknell, Berkshire, as of the end of April. The new 10,000-square foot facility includes state-of-the-art demonstration rooms and enhanced training areas. Baxa Corporation’s investment in Baxa Ltd’s new Berkshire location provides a foundation for rapid sales expansion in the UK and across Europe. - April 05, 2006 - Baxa Corporation
VM Discovery and Fred Hutchinson Cancer Research Center Team on Cancer Drug Discovery
Collaboration Focuses on Compounds Against an Important Cancer Pathway - VM Discovery Inc., a drug-design and discovery company, and Fred Hutchinson Cancer Research Center today announced they have entered into a collaboration to jointly pursue a cancer-drug discovery program. - March 31, 2006 - VM Discovery, Inc.
Baxa to Feature ValiMed™ Medication Validation System at Interphex 2006
Baxa Corporation features the innovative ValiMed System technology for rapid validation of high-risk medications at the Interphex 2006 trade show March 20-23, 2006, at Booth # C302. This new system provides the only effective means for preventing med errors, detecting narcotic abuse and ensuring the quality of batch compounds. - March 20, 2006 - Baxa Corporation
Baxa Corporation’s Jeff Baldwin Honored as a Top Business Leader by the Denver Business Journal
In an awards ceremony held Friday at the Denver Marriott City Center, Baxa President and Chief Operating Officer Jeff Baldwin was recognized as one of the top 40 business and community leaders in the Denver area. The 2006 winners were chosen on three criteria: business leadership, personal accomplishment and community involvement. - March 18, 2006 - Baxa Corporation
Blue Sky Biotech, Inc Names Dr. Norman Garceau, Former Scientist at Pfizer Global Research and Development, as Chief Scientific Officer
Blue Sky Biotech, Inc. announced the Feb 1st appointment of Norman Garceau, Ph.D., as Chief Scientific Officer. Dr. Garceau previously worked in early drug discovery at the Pfizer Research Technology Center (Cambridge, MA) from 1999 to 2006, engaged in a range of activities that included gene cloning and expression profiling, cell biology, assay development, and lead discovery. - March 15, 2006 - Blue Sky Biotech, Inc.
Antibodies are the First Wave of IGF-1R Antagonists for Cancer Therapy
At least six fully human or humanized antibodies against insulin-like growth factor-1 receptor (IGF-1R) are in early clinical development or close to phase I. - March 07, 2006 - La Merie Business Intelligence
Baxa Automated Pharmacy Production Equipment on Show at the European Association of Hospital Pharmacist’s Congress
UK-based pharmacy products supplier, Baxa Ltd will feature its proprietary systems for automating pharmacy fluid handling and streamlining multi-source mixing applications at the 11th annual Congress of the European Association of Hospital Pharmacists (EAHP) in Geneva from 22nd to 24th March 2006. The EAHP Congress, entitled ‘Quality and Medication Safety Hand in Hand,’ will focus on quality and safety improvements within the pharmacy and reducing patient risk. - March 02, 2006 - Baxa Corporation
Dawn has Broken for Obesity Treatment with Cannabinoid Receptor (CB1) Antagonists
Tremendous impetus to discovery of novel CB1 antagonists by first-in-class CB1 receptor antagonist rimonabant under review by FDA and EMEA - February 22, 2006 - La Merie Business Intelligence
Top 20 Biologics Now with Sales of US$ 37.7 Bln in 2005
The Top 20 blockbuster recombinant proteins and antibodies achieved record sales of US$ 37.7 bln in the year 2005 while combined sales of the 12 Top selling classes of recombinant proteins and antibodies reached the US$ 50 bln threshold. - February 15, 2006 - La Merie Business Intelligence
Baxa Announces the release of New Adapta-Cap™ Bottle Adapter
New cap fits sterile water bottles, expanding the line of Baxa accessories that facilitate easy access with Exacta-Med® Oral Dispensers. Designed to ensure dose accuracy while preventing med errors and wrong-route administration of IV drugs, oral dispensers and accessories are recommended by the Institute for Safe Medication Practice (ISMP) for use in oral and enteral fluid drug delivery. - February 09, 2006 - Baxa Corporation
Dosing Convenience Mandates the Pipeline of Glucagon-like Peptide-1 (GLP-1) Analogs for Type 2 Diabetes
Twice-daily injection is the benchmark set by exenatide, the first GLP-1 analog launched in the US by Lilly in June 2005 and half-year sales of US$ 74.6 mln, which now faces competition by GLP-1 analog treatment modalities with less frequent dosing. - February 07, 2006 - La Merie Business Intelligence
Emerging Diabetes Drugs in Early Development
The complexity of glucose metabolism and the number of cellular processes affected by diabetes provides ample space for new drug targets and for first-in-class molecules. Some of them have reached or are close to early clinical development in type 2 diabetes. - January 31, 2006 - La Merie Business Intelligence
High Interest in Inhibitors of the Novel Target Sodium-dependent Glucose (co-) Transporter (SGLT) for Therapy of Type 2 Diabetes
A plethora of SGLT inhibitors in the patent literature and seven compounds in early clinical development indicate an abundance of interest in the therapeutic use of SGLT inhibitors for the treatment of type 2 diabetes. SGLT inhibitors do not intervene with glucose metabolism, thus being complementary to mainstream approaches to glucose regulation, i.e. PPAR agonists, DPP-IV antagonists and GLP-1 analogues. - January 24, 2006 - La Merie Business Intelligence
Force Sensor for Datalogging in Schools
ScienceScope launch their new Force Sensor. As one of the UK’s leading developers of datalogging equipment that provides technology-based science learning solutions, ScienceScope have developed the new low cost Force sensor. The Force sensor is designed to measure in a range ±50N. - January 15, 2006 - ScienceScope